130 results
Page 4 of 7
8-K/A
EX-99.1
7xrnvixf
5 Mar 21
Financial Statements and Exhibits
4:15pm
8-K/A
EX-99.2
kosbq0o
5 Mar 21
Financial Statements and Exhibits
4:15pm
D
0if91ah5
21 Jan 21
$8M in equity / options / securities to be acquired, sold $8M, 1 investor
4:15pm
8-K
EX-10.1
y3ibewgrxan9ndiwq
6 Jan 21
EyeGate Enters Into Agreement for $8.0 Million Private Placement
6:55am
8-K
EX-10.2
sj78x
6 Jan 21
EyeGate Enters Into Agreement for $8.0 Million Private Placement
6:55am
D
j3vt71yf exqd1t1avxs
4 Jan 21
Indefinite amount in equity, sold $3.2M, 15 investors
12:00am
8-K
EX-2.1
fef93
21 Dec 20
EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma
6:55am
8-K
EX-10.1
ndd1w7r9u rk
21 Dec 20
EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma
6:55am
DEFA14A
6zi0s8 7nfont90wkpm9
29 Apr 20
Additional proxy soliciting materials
4:16pm
D
vcnq54uemrr 7gc
15 Jan 20
Indefinite amount in options / securities to be acquired, 5 investors
4:15pm
424B5
9ja mwy13thpp
31 Dec 19
Prospectus supplement for primary offering
4:28pm
8-K
EX-10.1
fp1vdbm85
31 Dec 19
EyeGate Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:05pm